SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,055 | +47.7% | 148,941 | +39.5% | 1.45% | +57.2% |
| Q2 2023 | $12,226 | +598.6% | 106,760 | +740.6% | 0.92% | +701.7% |
| Q1 2023 | $1,750 | +68.4% | 12,700 | +58.4% | 0.12% | +66.7% |
| Q4 2022 | $1,039 | -99.8% | 8,019 | +110.7% | 0.07% | +137.9% |
| Q3 2022 | $421,000 | -98.5% | 3,805 | -99.0% | 0.03% | -97.5% |
| Q1 2021 | $27,659,000 | +111.2% | 371,107 | +383.2% | 1.18% | +101.5% |
| Q4 2020 | $13,094,000 | -11.9% | 76,803 | -27.5% | 0.58% | -21.6% |
| Q3 2020 | $14,870,000 | -32.3% | 105,886 | -22.7% | 0.74% | -47.4% |
| Q2 2020 | $21,969,000 | +189.0% | 137,016 | +76.3% | 1.41% | +135.3% |
| Q1 2020 | $7,601,000 | +171.6% | 77,701 | +258.3% | 0.60% | +249.4% |
| Q4 2019 | $2,799,000 | +7464.9% | 21,689 | +4272.8% | 0.17% | +8500.0% |
| Q3 2019 | $37,000 | +27.6% | 496 | +101.6% | 0.00% | +100.0% |
| Q1 2019 | $29,000 | -21.6% | 246 | -27.9% | 0.00% | -50.0% |
| Q4 2018 | $37,000 | – | 341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |